Podcasts about healthcare sector

In this What's Next with Aki Anastasiou interview, John van Kan discusses the importance of incorporating new technologies into Standard Bank's healthcare banking solutions. Van Kan is the Head of Healthcare Sector, Business and Commercial Banking at Standard Bank and has worked in the banking sector since 2000. In this What's Next interview, van Kan explains how Standard Bank plays a key role in South Africa's healthcare sector. He discusses the major milestones it has achieved in the medical banking sector, and how Standard Bank is adapting to the industry's biggest challenges. Van Kan also explains how Standard Bank supports private medical practices, and reveals several initiatives the bank plans to introduce to support the South African healthcare sector further. He additionally details Standard Bank's view on the NHI, noting the positives it may offer to South Africans. Van Kan concludes the interview by sharing his advice for healthcare professionals and business owners to strengthen their financial resilience and grow in a competitive industry.

Karen Anderson, director of healthcare equity research for Morningstar Research Services, discusses the forces shaping the landscape and where she sees opportunities for investors.  Key Takeaways:Why Healthcare Stocks Have Been Resilient During the Market DownturnHow Regulatory Changes Could Affect the Healthcare IndustryWhy Healthcare Stocks' Valuations Look Attractive From a Bottom-Up ViewHow Have Healthcare Stocks' Valuations Changed Historically?How Stock Valuations Differ Within the Healthcare Sector  How an Aging US Population Affects the Healthcare Sector  Will GLP-1 Drugs Continue to Grow?  Regulatory Risks for Healthcare Stocks  Healthcare Stocks Outlook  Are Healthcare Stocks a Buy?  Healthcare Stock Picks  How Amgen Is Using AI in Healthcare   Read about topics from this episode.  Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity DataNovo Nordisk: Next-Generation GLP-1/Amylin Drug Sees Leading Weight Loss in Small TrialHow GLP-1 Drugs Like Ozempic Are Boosting Biopharma StocksBiopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges22 Best Healthcare Companies to Invest In  What to watch from Morningstar.Worried About a Market Sell-Off? These 10 Funds Reduce Portfolio Risk Gray Divorce: How to Avoid Triggering a Costly Tax BillWhy the Bond Market Looks Brighter Than It Did in 2022Where to Find Bargain Stocks in an Expensive Market  Read what our team is writing:Karen AndersenSarah Hansen Follow us on social media.Facebook: https://www.facebook.com/MorningstarInc/X: https://x.com/MorningstarIncInstagram: https://www.instagram.com/morningstar... LinkedIn: https://www.linkedin.com/company/5161/ 

On this episode of the Astonishing Healthcare podcast, Bloomberg Intelligence's Jonathan Palmer (Sr. Equity Analyst & Team Lead, Healthcare) joins us in the studio for a discussion about the work his team does and the evolving landscape of health tech. Palmer notes interest in Hinge Health's potential IPO and how the market's receptivity to tech-enabled healthcare companies has improved recently. While these companies face pressure to demonstrate profitability amid evolving market dynamics, there's optimism about innovation on several fronts. He also explains the impact of health policy uncertainty and questions about what the FDA, FTC, DOJ, and CMS will do on investors' ability to place bets: ambiguity causes market hesitation, and investors gravitate toward safe havens.The discussion also covers areas of focus for 2025, including:Palmer's favorite Vanguards of Healthcare podcast episodes and why he enjoys speaking with private company CEOs and venture capital leadersBiopharma Innovation, including GLP-1s, oncology readoutsMedTech Advancements like surgical robotics, cardioablation, and evolving insulin delivery systemsCapital Spending Concerns as US providers and China's healthcare sector are under scrutinyHealthcare Services: online pharmacy growth and Medicare Advantage trendsReference Materials Courtesy of Bloomberg IntelligenceNorth America Managed-Care Policy OutlookN.A. Health-Care Tech, Distribution: 2025 OutlookRelated ContentVanguards of Health Care: How Capital Rx is Fixing America's Broken Drug PricingAH057 - How First-Movers are Taking Control of their Health Plans in 2025, with Jeff HoganAH047 - What Project 2025, RFK Jr., and Dr. Oz Could Mean for the Business of Healthcare Under TrumpAH046 - What's Hot In and Around the Pharmacy Supply Chain, with RSM's Tom EveganFor more information about Capital Rx and this episode, please visit Capital Rx Insights.

SA Healthcare Sector Faces Funding Crisis Amid US Aid Cuts by Radio Islam

A health crisis looms as US funding for HIV/AIDS programs in South Africa faces the axe. With over 1,250 NGOs at risk, millions could lose access to vital treatment. Dr. Ndiviwe Mphothulo joins Africa Melane to unpack the impact and what can be done to protect South Africa’s progress in the fight against HIV.See omnystudio.com/listener for privacy information.

In this episode of Security Heroes, host Lisa Falzone is joined by Mel Cortez, Founder of Cortex - GOLD, a Nurse and Veteran owned company that gives healthcare organizations a personalized tool-kit that establishes a culture of safety by mitigating workplace violence. Previously a Travel Registered Critical Care Nurse, Mel joins the show today to discuss challenges nurses face in the emergency room. Join them as they: Delve into the catalytic event that triggered the conception of Cortex - GOLD Explain how Cortex - GOLD helps organizations to effectively deal with incidents such as the catalytic event Mel experienced Talk about how Mel used her own experience of workplace violence to affect a different outcome in similar situations Examine the implications of nurses bearing the brunt of workplace violence Shine a light on Mel's first experience saving a life Discuss the harsh realities of workplace violence in the healthcare sector

Welcome to your weekly dose of Rise UP!, where we break down the week's top market and economic events to help you stay ahead of the curve. In this episode, your hosts, Terri Kallsen, CFP®, and Joe Duran, CFA, along with special guest David Mandelbaum, Portfolio Manager at Bleakley Financial Group, will tackle the hottest financial topics. Here's what's on the agenda: Market Surges Amidst Economic Uncertainty: We analyze the S&P 500's surprising rally despite mixed economic signals, including rising inflation rates and strong earnings reports. Healthcare Sector's Unforeseen Dip: We examine the healthcare industry's unexpected underperformance and discuss if this presents a unique opportunity for savvy investors. Capital One's Consumer Controversy: We delve into the lawsuit against Capital One, exploring its implications for both consumers and investors. Plus, we'll address your burning questions on: Financial preparedness in the face of natural disasters Insurance dilemmas Economic forecasts for Canada and Japan Policy changes under the new administration Meet the Hosts: Terri Kallsen, CFP®, former head of Schwab Investor Services, Chair of the CFP Board, and Managing Partner at Rise Growth Partners. Joe Duran, CFA, serial entrepreneur, Goldman Sachs alum, and founder of Rise Growth Partners, one of the largest RIAs in the U.S. Don't miss out on this insightful episode filled with actionable advice and expert insights. Chapters: 00:00:00 - Introduction 00:02:17 - Market Performance and Economic Indicators 00:07:45 - Healthcare Industry Analysis 00:15:45 - Capital One Lawsuit 00:21:09 - Financial Preparedness for Disasters 00:29:29 - Insurance Concerns 00:30:32 - Economic Outlook: Canada and Japan 00:33:12 - Policy Implications and Portfolio Strategy 00:35:45 - Conclusion Connect with us online: Website: https://www.wealthion.com X: https://www.x.com/wealthion Instagram: https://www.instagram.com/wealthionofficial/ LinkedIn: https://www.linkedin.com/company/wealthion/ #Wealthion #Wealth #Finance #Investing #Markets #Economy #StockMarket #FinancialPlanning #MarketRecap #InvestmentTips #PersonalFinance #EconomicInsights #MoneyManagement #FedPolicy #MarketTrends ____________________________________ IMPORTANT NOTE: The information, opinions, and insights expressed by our guests do not necessarily reflect the views of Wealthion. They are intended to provide a diverse perspective on the economy, investing, and other relevant topics to enrich your understanding of these complex fields. While we value and appreciate the insights shared by our esteemed guests, they are to be viewed as personal opinions and not as official investment advice or recommendations from Wealthion. These opinions should not replace your own due diligence or the advice of a professional financial advisor. We strongly encourage all of our audience members to seek out the guidance of a financial advisor who can provide advice based on your individual circumstances and financial goals. Wealthion has a distinguished network of advisors who are available to guide you on your financial journey. However, should you choose to seek guidance elsewhere, we respect and support your decision to do so. The world of finance and investment is intricate and diverse. It's our mission at Wealthion to provide you with a variety of insights and perspectives to help you navigate it more effectively. We thank you for your understanding and your trust. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the final Weekly Wrap of 2024, Grady recaps a year of strong performance for the ASX. Key factors for 2025 include potential rate cuts, China's economic recovery, and the impact of new US trade policies. The healthcare sector is poised for growth, and the ASX is expected to rise further.   In this week's wrap, Grady covers:(0:11): how the ASX performed in 2024(0:39): China's economic recovery & growth rate(3:38): why the healthcare sector underperformed(4:37): the best & worst performing stocks on the ASX this week(5:35): the most traded stocks by Bell Direct clients(6:02): economic news items to watch out for.

It's Fed Day with it's much anticipated rate cut; what will matter more is the Fed's dot-plot and comments on expectations for 2025. Meanwhile on Wall Street, sloppy trading continues as fund manager rebalance portfolios. Markets are sitting on the 20-DMA and holding firm. The Healthcare Sector is the year's worst performer: Will it offer the most opportunity in 2025? This sector tends to perform better AFTER elections. Lance reveals a new temptation on his route to work each morning; Lance and Danny comment on the notion of dumping the traditional 60/40 portfolio in favor of 100% stocks for retirement, with charts and graphs. More commentary on those who would think they can beat the market, and what's in store if the show goes straight to YouTube (no filter). Old maxims about investing no longer hold true with the velocity of information and distortion of the markets. Why does no one want Value Stocks anymore? Lance and Danny recall reading encyclopedias as youths. The thing about Roth conversions...what are the chances taxes will go lower? SEG-1: Fed Day - What Will They Say? SEG-2: Dumping the 60/40 Portfolio? SEG-3: So You Think You Can Beat the Market? SEG-4: Why No One Wants Value Stocks Hosted by RIA Advisors Chief Investment Strategist Lance Roberts, CIO, w SSenior Financial Advisor Danny Ratliff, CFP, Produced by Brent Clanton, Executive Producer ------- Watch today's show video here: https://www.youtube.com/watch?v=ElTw9jd0hg8&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=2s ------- Articles mentioned in this report: "Permabull? Hardly." https://realinvestmentadvice.com/resources/blog/permabull-hardly/ "Trump Election Sends NFIB Optimism Surging" https://realinvestmentadvice.com/resources/blog/trump-election-sends-nfib-optimism-surging/ ------- The latest installment of our new feature, Before the Bell, "Opportunities Ahead in Beaten Down Stocks?," is here: https://www.youtube.com/watch?v=4HqWOpYV_Qs&list=PLwNgo56zE4RAbkqxgdj-8GOvjZTp9_Zlz&index=1 ------- Our previous show is here: "This is Nuts" https://www.youtube.com/watch?v=drZL-tygAg0&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=1314s ------- Get more info & commentary: https://realinvestmentadvice.com/newsletter/ -------- SUBSCRIBE to The Real Investment Show here: http://www.youtube.com/c/TheRealInvestmentShow -------- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN -------- Subscribe to SimpleVisor: https://www.simplevisor.com/register-new -------- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #RetirementPlanning #InvestmentStrategy #StocksForRetirement #FinancialIndependence #PortfolioManagement #StockMarket2024 #MarketVolatility #InvestorInsights #BullOrBear #Microstrategies #SP100 #OilPrices #SlowingEconomy #GoldPrices #GoldCorrection #USDollar #EconomicGrowth #SmallBusinessOptimism #NFIBReport #EconomicTrends #BusinessConfidence #FinancialTalk #InvestingAdvice #Money #Investing

It's Fed Day with it's much anticipated rate cut; what will matter more is the Fed's dot-plot and comments on expectations for 2025. Meanwhile on Wall Street, sloppy trading continues as fund manager rebalance portfolios. Markets are sitting on the 20-DMA and holding firm. The Healthcare Sector is the year's worst performer: Will it offer the most opportunity in 2025? This sector tends to perform better AFTER elections. Lance reveals a new temptation on his route to work each morning; Lance and Danny comment on the notion of dumping the traditional 60/40 portfolio in favor of 100% stocks for retirement, with charts and graphs. More commentary on those who would think they can beat the market, and what's in store if the show goes straight to YouTube (no filter). Old maxims about investing no longer hold true with the velocity of information and distortion of the markets. Why does no one want Value Stocks anymore? Lance and Danny recall reading encyclopedias as youths. The thing about Roth conversions...what are the chances taxes will go lower? SEG-1: Fed Day - What Will They Say? SEG-2: Dumping the 60/40 Portfolio? SEG-3: So You Think You Can Beat the Market? SEG-4: Why No One Wants Value Stocks Hosted by RIA Advisors Chief Investment Strategist Lance Roberts, CIO, w SSenior Financial Advisor Danny Ratliff, CFP, Produced by Brent Clanton, Executive Producer ------- Watch today's show video here: https://www.youtube.com/watch?v=ElTw9jd0hg8&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=2s ------- Articles mentioned in this report: "Permabull? Hardly." https://realinvestmentadvice.com/resources/blog/permabull-hardly/ "Trump Election Sends NFIB Optimism Surging" https://realinvestmentadvice.com/resources/blog/trump-election-sends-nfib-optimism-surging/ ------- The latest installment of our new feature, Before the Bell, "Opportunities Ahead in Beaten Down Stocks?," is here:  https://www.youtube.com/watch?v=4HqWOpYV_Qs&list=PLwNgo56zE4RAbkqxgdj-8GOvjZTp9_Zlz&index=1 ------- Our previous show is here: "This is Nuts" https://www.youtube.com/watch?v=drZL-tygAg0&list=PLVT8LcWPeAugpcGzM8hHyEP11lE87RYPe&index=1&t=1314s ------- Get more info & commentary:  https://realinvestmentadvice.com/newsletter/ -------- SUBSCRIBE to The Real Investment Show here: http://www.youtube.com/c/TheRealInvestmentShow -------- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN -------- Subscribe to SimpleVisor: https://www.simplevisor.com/register-new -------- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #RetirementPlanning #InvestmentStrategy #StocksForRetirement #FinancialIndependence #PortfolioManagement #StockMarket2024 #MarketVolatility #InvestorInsights #BullOrBear #Microstrategies #SP100 #OilPrices #SlowingEconomy #GoldPrices #GoldCorrection #USDollar #EconomicGrowth #SmallBusinessOptimism #NFIBReport #EconomicTrends #BusinessConfidence #FinancialTalk #InvestingAdvice #Money #Investing

Explore how South Africa is revolutionizing healthcare with our wellness presenter and mental fitness coach Liezel van der Westhuizen. Discover groundbreaking initiatives, successful HIV treatment programs, and the transformative impact of technology on healthcare delivery. Tune in for inspiring success stories and expert advice on improving health outcomes for all South AfricansSee omnystudio.com/listener for privacy information.

The UCD Professional Academy, Ireland's leading destination for professional development and upskilling, has launched its latest industry insights report exploring the Irish healthcare industry's challenges and the current skills gaps. The new report, Tackling Digital Transformation in Healthcare, is the second in a series of industry analyses by UCD Professional Academy. With the industry undergoing unprecedented technological advancements in recent years, there is a clear need for a shift in how organisations approach patient care, data management, and operational efficiency. Digitalised healthcare has the potential to change Irish lives and livelihoods by revolutionising patient care and shaping the society we live in. According to the UCD Professional Academy's latest industry insights report, digital transformation is rapidly reshaping the healthcare sector and has the potential to revolutionise patient care while improving operational efficiency and staff wellbeing. The Irish healthcare sector already recognises the crucial need for digitalisation and Ireland is well-placed to become a global business hub in digital health but faces a significant challenge: a shortage of suitably skilled healthcare professionals. This challenge is widely recognised but one that Ireland is currently struggling to meet, both in terms of staffing and digital ability. This new report has identified three clear mechanisms to bridge the skills gap and allow Ireland to harness the full benefits of digital health: Fostering a culture of innovation and continuous learning Short, flexible and ongoing training options for busy healthcare professionals Digital literacy and change management skills for healthcare leaders to steer transformation UCD Professional Academy is partnering with organisations across the healthcare industry to ensure they can meet their upskilling needs through industry-taught and industry-led professional development courses. Commenting on the launch of the report, John Delves, CEO of UCD Professional Academy said: "The digital transformation of healthcare presents several challenges and opportunities for the industry in Ireland. While potential benefits are immense, realising them requires a workforce equipped with the necessary digital skills and a leadership team capable of driving change. This report highlights the urgency of addressing the digital skills gap, ensuring the focus is not only on equipping employees with specific digital skills but training leaders to manage the changes needed. By investing in both digital and leadership skills, Irish healthcare organisations can create a situation where everyone benefits, boosting patient and staff health and well-being and the health of Ireland's economy. Our goal at UCD Professional Academy is to help our partners to learn and thrive across Ireland. We offer tailored courses to partners that offer industry-specific content curated directly for healthcare professionals that can assist them with bridging the digital gap and prosper in their industry." The report is available online here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In this episode, Scott Becker and Alan Condon, Editor-in-Chief at Becker's Healthcare, explore the ongoing challenges facing nonprofit health systems, including high labor costs and inflation. They discuss why some systems are outperforming others and highlight key market expansions by both nonprofit and for-profit hospitals in high-growth regions.

2024 is shaping up to be a surprisingly robust year for private equity deal activity.

In this episode of the Cyber Uncut podcast, Peter Maloney, CEO and managing director of AUCloud, joins host Liam Garman to examine the 71 per cent year-on-year increase in cyber attacks against healthcare systems and the risks that this will pose for regular Australians. The pair begin the podcast by unpacking key findings from the 2024 Cyber Security Healthcare Report and the key factors that contribute to this alarming trend. Maloney then provides insight into the Monash Health and MediSecure data breaches and what steps that healthcare providers must take to prevent future breaches. They wrap up the podcast by looking at the ethical implications of healthcare data breaches, while Maloney details the must-need strategies and technologies to ameliorate this risk. Enjoy the podcast, The Cyber Uncut team

A key trend in healthcare is the growing use of Artificial Intelligence (AI), expected to transform the sector in various ways. Given these developments, what are the prospects for Malaysia's healthcare sector and which listed companies stand to benefit? Imran Yusof, Head of Research at MIDF Investment Bank gives us those answers.Image Credit: freepik.com

Midwifery has the greatest shortfall of the health care sector, to fill the gaps an extra 300 students need to graduate a year. But one new graduate has told Checkpoint financial pressure makes the degree unsustainable, over 70 percent of her class had dropped out by the time she graduated, Louise Ternouth reports. On her first day, Beth Fisher-Evans says students were told having a job on top of studying would be impossible. She says getting her degree was a constant juggle of classwork on top of placement hours - when a patient could go into birth at any time.

In this week's Security Sprint, Dave and Andy talked about the following topics. FB-ISAO Threat Assessment Statement: Threat Levels Remain at Elevated – July 2024 FB-ISAO Updates! FB-ISAO Newsletter, v6, Issue 7 The FB-ISAO FireArms in the House Series: What Did We Learn? WaterISAC Surpasses 600 Members, Strengthening Water and Wastewater Security Nationwide Critical infrastructure organizations want CISA to dial back cyber reporting Real Estate Coalition Raises Concerns Over Cyber Reporting Requirements Briefing 23: Space Sector at Risk as Ransomware Groups and Nation State Actors Collaborate Guarding Health: Errol Weiss on Protecting the Healthcare Sector from Cyber Threats  Assassination Attempt FBI, DHS warn of possible retaliation for attack on Trump FBI Update on the FBI Investigation of the Attempted Assassination of Former President Donald Trump Secretary Mayorkas Delivers Remarks at White House Press Briefing Statement From U.S. Secret Service Director Kimberly Cheatle DHS secretary says direct line of sight 'should not occur' in wake of Trump assassination attempt What We Know—and Don't Know—So Far About the Trump Rally Gunman Rooftop where gunman shot at Trump was identified as a security vulnerability before rally: sources Secret Service investigating how gunman was able to get so close to Trump Local Cop Confronted Trump Gunman Before Shooting—but Backed Away New information emerges on Trump shooting suspect Misinfo: Misinformation spreads swiftly in hours after Trump rally shooting Social Media Platforms Deluged by Unsubstantiated Claims About Trump Rally Conspiracy theories about the Trump rally shooting flourish online Trump Assassination Attempt Sparks Antisemitic Conspiracy Theories and Violent, “Revenge” Rhetoric Far-Right Extremists Call for Violence and War After Trump Shooting Donald Trump talks unity after shooting attempt   Copa America final kick-off delayed after fans struggle to enter stadium in Miami Copa America final delayed after hordes of fans climb vents, walls to ‘forcibly enter' Hard Rock Stadium in chaotic scene Copa América final start delayed after fans rush gates Copa America security disaster ‘not a good look' for US ahead of World Cup: Alexi Lalas Venue Security, The IAVM Podcast Series: Throwing down the gauntlet with Brendan Farley as we discuss the art and science of crowd management. The Gate 15 Interview: Dr. G. Keith Still on crowd security, drinking whisky, smashing ashtrays in Saudi Arabia, the Land of Ice and Fire, and what not to ask a Scotsman. 24 Jul 2023. Nerd Out Security Panel Discussion: EP 19. Talking Crowd Control and the Holidays – in 2 Parts! Nov 2021. Quick Hits A Globally Integrated Islamic State Tenuous Taliban control gives life to al-Qaida, Islamic State Goldman Sachs: AI Is Overhyped, Wildly Expensive, and Unreliable. Justice Department Leads Efforts Among Federal, International, and Private Sector Partners to Disrupt Covert Russian Government-Operated Social Media Bot Farm TikTok Content Farms Use AI Voiceovers to Mass-Produce Political Misinformation CSU's 2024 Atlantic seasonal hurricane forecast was released on 4 April and updated on 9 July Colorado Reports Three Presumptive Positive H5 Cases in Poultry Workers Bird flu spread to cows takes 'dangerous' step towards infecting humans through respiration, scientists warn AT&T Discloses Breach of Customer Data US and Germany foiled Russian plot to assassinate CEO of arms manufacturer sending weapons to Ukraine New Jersey Man Charged with Soliciting Destruction of Energy Facilities Victims of cyber extortion and ransomware increase in 2024 Orange Cyberdefense: Cy-Xplorer 2024 - When bits turn to blackmail - all about ransomware and cyber extortion Black man dies, crying for help, after hotel guards pin him down, video shows CISA Releases Insider Threat Reporting Templates

The healthcare industry is one of the most vulnerable sectors to cybersecurity risk. In this episode of the MedTech podcast, Freshfields partners Vinita Kailasanath and Brock Dahl explore some recent examples of credible threats to the industry and how companies can implement technological innovation to help mitigate these risks.

The healthcare sector recently faced a significant cybersecurity challenge with a ransomware attack in June, highlighting critical vulnerabilities in patient data protection. This incident brings to light the importance of healthcare organizations to prioritize robust cybersecurity strategies to avoid the risk of losing personal information of patients. Joining me to discuss the implications of this is and how it can be mitigated is Reza Joseph, ICT and Network Security Product Manager at Itec South Africa.See omnystudio.com/listener for privacy information.

In this episode of Coffee with Coker, Mark Reiboldt, EVP at Coker, and Vinson Do discuss the impactful role of AI in the business side of healthcare. They delve into how AI is transforming claims processing, medical coding, and healthcare reimbursement. The conversation highlights real-world examples, such as the AI implementation at Community Medical Centers of Fresno and Mass General Brigham, which have shown significant improvements in reducing denials and enhancing coding accuracy. Ethical considerations and future prospects for AI in healthcare are also examined. 00:25 The Role of AI in Healthcare 00:53 Introducing Vinson Do and AI's Impact 01:51 Understanding Artificial Intelligence 04:43 AI in Claims Processing 11:37 AI in Medical Coding 16:32 AI in Healthcare Reimbursement 23:14 Ethical Considerations and Future Prospects 30:53 Conclusion and Final Thoughts Podcast Information Follow our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.  ·        Please email us: feedback@cokergroup.com ·        Connect with us on LinkedIn: Coker Group Company Page ·        Follow us on Twitter: @cokergroup ·        Follow us on Instagram: @cokergroup ·        Follow us on Facebook: @cokerconsulting

Dr. Joy is the Chief Medical Officer for Lore Health. Prior to that, she served as Senior Medical Director for Wellness and Nutrition at Intermountain Health in Salt Lake City, UT. She received her B.S. and M.D. degrees at the University of Minnesota, and M.P.H. from the University of Utah. She completed her Family Medicine Residency and Sports Medicine Fellowship at Hennepin County Medical Center in Minneapolis, MN. She is an adjunct faculty member at the University of Utah School of Medicine in the Department of Family and Preventive Medicine, and in the College of Health Department of Nutrition & Integrative Physiology. Dr. Joy is the Past President of the American College of Sports Medicine (ACSM), and the Female Athlete Triad Coalition. She Chairs the Exercise Is Medicine Governance Committee for the ACSM, and serves on the Board of Directors, and Chairs the Healthcare Sector for the National Physical Activity Plan. Her research interests lie in the areas of diabetes prevention, physical activity promotion, and the Female Athlete Triad.For information about my upcoming Online Yoga For Dudes, Brand-New Beginner's Course - email me directly at jpanasevich@gmail.com, or call or text me at 267.275.3890.

Simply Wall St Market Insights for the week ending 9th June 2024. To read the full article: Why The Healthcare Sector Has Been Underperforming Create a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FREE account for Simply Wall St⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to get access to these insights, and fundamental analysis on tens of thousands of stocks all over in the world! Our 6-part "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Invest with confidence⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠" series.

Healthcare sector endures surge in cybersecurity attacks, faces headwinds in effort to respond, Podcast with David Lee - Vulnerabilities in outdated medical devices further exacerbate risks, enabling remote manipulation by hackers The Sunday TR Podcast David Lee transitioned from a software engineering background to become a harbinger of change and inclusivity in the tech world. “If you're a company today, as soon as you have a website, you're a tech company,” says David Lee, a noted industry expert in cybersecurity for twenty years, often focusing on call identity and access management. “It doesn't really matter if you're baking bread. In this case, if you are in the medical profession, you're selling plastic bottles, you are now in the tech company. And if you're a tech company, that means you're vulnerable to cybersecurity attacks and threats.” Healthcare, which includes a sprawling number of companies, organizations, suppliers, vendors, contractors and more, not only have the vulnerability of all tech companies, but have the added responsibility to safeguard patient records. In this podcast we look at the surge in cybersecurity attacks targeting the U.S. healthcare sector, evidenced by a significant increase in data breaches compromising millions of patient records in recent years. Specific incidents like the cyberattack on Change Healthcare underscore the severity of these breaches. Healthcare data breaches continue to be the most financially damaging across industries, costing millions per incident. Vulnerabilities in outdated medical devices further exacerbate risks, enabling remote manipulation by hackers. The healthcare sector's unique challenges, including reliance on closed-off technology and limited integration with external partners, amplify vulnerability to cyber threats. To address these issues, healthcare entities must adopt comprehensive cybersecurity strategies involving critical functions and stakeholders. However, the industry faces a significant shortage of skilled cybersecurity professionals, emphasizing the need for upskilling and training efforts. Effective cybersecurity practices rely not only on technologies but also on skilled individuals for successful implementation and management, underscoring the urgent need for improved cybersecurity measures in healthcare. David takes us for the big picture to how he helps organizations break the challenge down into bite size bits. “We're going to take a step at a time. Like, here's the 15 steps we're going to have to take. I don't want you to focus that on right now. Right now, step one to two, and then two to three, and then so forth and so on.” About David Lee David Lee transitioned from a software engineering background to become a harbinger of change and inclusivity in the tech world. With over two decades of experience, he has left his mark on government agencies, Fortune 500 companies, and numerous fields, specializing in identity and access management. Recognizing that for technology to truly transform the world, it must embrace diversity, David serves as an agent of transformation, inspiring individuals to unlock their full potential. His influential voice and actionable insights have solidified his reputation as a respected figure in the ever-evolving tech landscape. When he speaks people listen. He is The Identity Jedi. http://www.theidentityjedi.com. LinkedIn: https://www.linkedin.com/in/identityjedi/ Twitter: https://twitter.com/iamhdavidlee Healthcare sector endures surge in cybersecurity attacks

Thank you so much for listening to the Bob Harden Show, celebrating over 12 years broadcasting on the internet. On Thursday's show, we discuss the most recent Collier County School Board meeting and upcoming events including the non-partisan candidate forums held this month with Keith Flaugh, Co-Founder of the Florida Citizens Alliance. Director of Health Policy Studies at the Cato Institute Michael Cannon I discuss the myth of the “free market” healthcare sector. The President of Less Government Seton Motley and I discuss his experience of becoming an entrepreneur in Belize. We also visit with the Former Mayor of Naples, Bill Barnett. We have terrific guests scheduled for Friday's show including Pacific Legal Foundation's William Yeatman, and author and Professor Larry Bell. Please access this or past shows at your convenience on my web site, social media platforms or podcast platforms.

Connect with Chenchao Liu on LinkedInVisit SILREALs websiteVisit Asia Business Podcast Full show Transcript below Summary and TimestampsOverviewIn this episode of the Asia Business Podcast, host Art Dicker interviews Chenchao Liu, the founder of SILREAL, a management consulting firm focusing on healthcare and Sino-European business exchanges. Chenchao shares his journey from China to Germany, his transition from science to business, and the mission of bridging the healthcare sectors between China and the West. They discuss the unique collaboration opportunities in pharmaceuticals and healthcare services between China and Europe, navigating political barriers, and the impact of regulations like IP protection and data sharing laws. The conversation delves into the challenges and trends reshaping the industry in China, including the aging population, health consciousness post-COVID, and the dynamics of foreign companies adapting to China's volume-based pricing system. Timestamps00:00 Introduction to the Episode and Guest00:41 Chenchao Liu's Journey from China to Germany and Founding SILREAL01:49 Bridging Sino-European Business in Healthcare02:54 Exploring Recent Projects and the Impact of SILREAL's Work05:03 Opportunities for China-Europe Collaboration in Healthcare08:20 Navigating Political Barriers in Sino-European Relations16:23 The Impact of Regulations on Cross-Border Healthcare Collaboration21:15 Macro Trends Shaping the Healthcare Industry in China31:16 Concluding Remarks and How to Connect with Chenchao Liu TranscriptArt: [00:00:00] Welcome everybody to another episode of the Asia Business Podcast. I'm your host, Art Dicker. Today we have the absolute pleasure of being joined by Chenchao Liu. Chenchao is the founder of SILREAL, a management consulting firm specializing in the healthcare sector [00:00:15] and fostering Sino European business exchanges.Art: Welcome Chenchao.Chenchao: Thank you, Art. Thank you for having me. Art: Yeah, we've been talking. We've been talking a few times over the last couple of years or so, and [00:00:30] it just seemed natural that we do a podcast. We've had long conversations, the two of us just talking about some of these things we're going to get into.Art: So it's, like I said, it's natural. We just record an episode about it. And, you were born in China, but you've lived in Germany for more than 20 [00:00:45] years now. And I was wondering if you could share a bit about your own kind Your own story behind the founding of SILREAL and then also help the audience understand a bit more kind of work you do to bridge the European Chinese markets in life [00:01:00] sciences.Chenchao: Yeah, thank you, Art. Thank you for really inviting me and I respect and follow your work for a while and appreciate that I could share some of my story here. Yeah, as you mentioned, yeah, I was born in [00:01:15] China in Qingdao, historical city connected to Germany. And I came to Germany when I was 13. So I went to elementary school, and I studied chemistry in Munich.Chenchao: And had very devoted concentration interested into [00:01:30] science and was very active. I high school already for Olympics and later for Mustang Institute ATH. But I realized later that due to the internship I did with consulting firms that I'm really belong to the business world.Chenchao: I [00:01:45] want to work with people. I want to be in real impact making. And yeah, so I after graduation, I went to consulting firm, I did a lot of projects for hospitals and also for private equities [00:02:00] in 2017 when I realized that I wanted to Do more things with China. I said to myself look into the mirror.Chenchao: You cannot just look like this way. It's better that you could do something content wise with the country [00:02:15] where you're from. And yeah, I started to advise some Chinese firms who come to Europe and vice versa. And yeah, and what is really entrepreneurial journey. Nobody has taught me how to build business, so really try and [00:02:30] arrow and yeah, I think it's combination of hard work, persistent and also support of others.Chenchao: We have thright and have again, some traction, have project from federal menstrual health and the state governments help some big [00:02:45] pharma like AstraZeneca. And yeah, I really want to be the bridge in life science healthcare between China and the West. Art: And can you talk a bit about some of the sort of the projects that you've worked on recently and[00:03:00] or so, some, so give the audience a really some context for some actual to the extent you're allowed to talk about it, but I know also we'll get into it.Art: You've got quite a. Number of wonderful endorsements on your websites from the projects you've worked on, but just [00:03:15] to give the audience a bit of wrap their heads around the actual kind of consulting work and so forth that you do. Chenchao: Yeah, thank you, Arthur. So basically, we have three main sectors of industries.Chenchao: We serve for health [00:03:30] care, life science and public sector. We have done digitalization project for health care providers in Germany. I helped them to modernize their 6000 employee. System of hrs and consolidate over [00:03:45] 20 entities. And also to transform how they track employee working time and management of the post recruitment retention.Chenchao: So other project we have done is really to bring [00:04:00] public and private sector together to tackle Corona diseases. To learn from each other between German China when it's come to for example, COPD. I think the strengths we can bring here is really to understand the [00:04:15] policy, understand the legal justice nature.Chenchao: But also to bridge, what does it make the difference between how Germany and China handle different disease areas. And lastly, as I mentioned for the government public sector we do [00:04:30] oftentimes delegation trips for ministry level for experts from insurance for hospital representative to really to understand how big countries like China, Israel and the U.Chenchao: S. Playing around in the [00:04:45] digitalization. And that's why I think it's very crucial especially in this age to have a active dialogue because I do think, as you mentioned, the before the trip for by the chancellor, there's this avenue of collaboration [00:05:00] is still very strong within the healthcare.Art: Yeah, let's jump into that, jump ahead into that question. The, in an ideal scenario, devoid of political barriers, and we'll get into those, maybe some of those political barriers in a 2nd, but, what are some of the [00:05:15] unique opportunities for collaboration between China and Europe in the, pharmaceuticals, biotechnology.Art: Health care services, because it seems like there's you've already hit on it a bit. There's naturally a lot of synergies. There's just by listening to some of the projects [00:05:30] you've supported so far. So without politics in the mix, what would be the, some of the more of those kind of natural synergies between between China and Europe in these sectors?Chenchao: Yeah, thank you. I think due to a large population, 1. [00:05:45] 5 billion in people in China, and it's already is the second biggest market in healthcare and pharmaceuticals and it's posed to become the biggest one but if you look at the per capital expenditure China is still lagging very [00:06:00] far behind.Chenchao: It's only around 10 percent or less, Of that expenditure per capita compared to European level. So there's a lot of to catch up and I think aging population China and also very high pressure for, [00:06:15] a younger generation birth rate. So there's a lot of issues within the society and also the plague by the chronic diseases in various forms.Chenchao: I just mentioned COPD, but there's also other ways and the cancer [00:06:30] and, uh, heart related diseases. And I think this is also very important after the COVID, like how to also in the community diseases are prevented. Measurement and the very [00:06:45] important role China can have. So I think this is really laid the ground for multinationals to really look into China and the force of their expansion.Chenchao: And despite all the attention we have touched on, I think there's a lot [00:07:00] of company. Are just announced even further and stronger presence in China, like as Seneca's new research facility in Hong Kong. In Heim also mentioned the billion of investment [00:07:15] going on. So there is still very strong sense that the market due to the high population, due to also the infrastructure because China is still at home.Chenchao: of a very strong, supplier for biosimilar and and [00:07:30] APIs for big pharmaceuticals around globe. So it's very crucial to have a healthy relationship with China to keep supply chain safe and secure. Art: Yeah, and that's actually in contrast a little bit to what's been going on in the U. S. [00:07:45] these days.Art: It's more and more Chinese companies are potentially Congress is in an election year here in the U. S., as is looking at more and more Chinese companies. And now that's extended to the bios and pharmaceutical sector as well, which is, I guess people thought might [00:08:00] happen, but maybe not so quickly.Art: So that's it seems like Europe is not it is quite different, which is I guess not surprising but that's been in the news here in the U. S. too. And it's living here in San Diego, California, where I know a lot of those, the Chinese companies and U. S. companies, [00:08:15] this is a place where they work together.Art: It's I don't know, a little bit disheartening to see that happening, but but I guess there's. Anyway, I won't get into the concerns but now that we do put let's say, we put politics to some of the tensions into the mix. How is that starting [00:08:30] at all to influence cooperation between China and Europe?Art: Like I said, China in the US, I think that's already definitely having an impact, but do you see that having an impact at all between China and Europe? Yeah, definitely. Are there are [00:08:45] big impacts. The question is like how, long term and how quantifiable other impacts. I think everything is put into perspective.Chenchao: I think compared to other industries health care amount climate are still Thank you. [00:09:00] Very strong, constructive avenue of collaboration, but I do agree with your assessment. There's a difference between US China, European China relationship, and I think underlined by the trip by Chancellor Scholz from [00:09:15] Germany with three ministers and all state secretary level people, three days.Chenchao: Very long stay. So it's a really strong signal not only to China, but to the rest of the world that we need a very strong dialogue. We need a very [00:09:30] strong, and the Stanford, even we cannot agree on everything on every issues. But I think this kind of. Very pragmatic approach that we need China also to solve major conflicts in Middle East in Ukraine, Russian conflict, [00:09:45] and others.Chenchao: I think this is just to serve, the best interests of the people who ultimately, At the say in the democracies in the West. So I think when it's come to industry politics I do believe that, of course [00:10:00] Europeans want to, have the access to Chinese market. At the same time, it's very critical.Chenchao: Look at at, also from the legislative and legal point of view, China. The IP laws, the cyber security laws, and also the [00:10:15] limitation data transfer. These are all the problems, especially also for R& D intensive industry like pharmaceuticals, biotech. And so this is a strong position for European part to get China more to create [00:10:30] a, a fair competition environment.Chenchao: So this has been a very strong agenda of the trip as well. I personally, as I said, I was organized of the delegation trip myself for the ministry level. And last year I was [00:10:45] invited for the delegation trip by the climate minister from Germany. So I do see a very strong willingness to collaborate.Chenchao: And to willingness to, to collaborate in field where common dialogue is [00:11:00] possible. And I'm very hopeful to see, and just to stay by Germany in June the economy, Mr. Habeck is going to China as well. So I do think that's within this year very crucial both to the election, as you mentioned, yes.Chenchao: [00:11:15] But also some very highly watched elections within the states in Germany. So yeah so China West relation has always been very significant. Art: Yeah, that's, I think there's, that's a great point. Look at that three days and high [00:11:30] level visits like that. And that's really, I don't think there's many other countries that do that.Art: So of course, certainly not the United States, but there's, that's that As you said, really would show a sign of commitment to the relationship and the markets [00:11:45] opportunities both ways even. And I did also read that Chancellor Schultz said that IP protection, you hit on it.Art: There is was maybe the chief concern of German companies. And I wonder if. We can get into that as a bit of a side [00:12:00] topic. Is that a is that still a concern for German companies in these sectors we've been talking about? Or is that more, let's say, in some of the traditional auto or other sectors that German companies have been also quite strong in is that I'm [00:12:15] talking about IP protection in China.Art: I know, because, of course, I practice law cross border there, and I can certainly. The audience, if they've been listening to me, know that I think that IP protection in China has gotten significantly better than it was [00:12:30] when I first started going over there. But I, like I said, Chancellor Schultz said that's still a primary concern for German companies.Art: Do you see that in your industries as well? Chenchao: I think one say it's reputation is hard to build but easy to lose, [00:12:45] right? So once you have a not very good reputation when it comes to IP protection, IP enforcement, and it's very hard to build back the reputation. I do agree on legislative level, China has already made progress and [00:13:00] had also You know enforce the law and to punish some of the companies who infiltrate the IP so I think I totally agree with your assessment, but the other hand, when it's come to all our confidence in Chinese market, when it's come to [00:13:15] IP, it is still very low slope recovery. So that's concern remains. And because there's also the effect of those high pace of regulatory changes in China, right?Chenchao: So we, we see A new laws coming in rapid [00:13:30] speed, there's no time to read, to digest, to understand the comment, not like the legislative cycles we know from the democratic system in the U. S. or in Europe, in the European Union. Everything's slower, people have time to debate, to [00:13:45] comment, and to see the final draft of the law might be totally different.Chenchao: In China, you have to really keep up the pace to understand the new laws, what is impact for the business. And I think the other very current issue art is also [00:14:00] when it's come to espionage law in China, and this has also direct. Impacting the pharmaceuticals company because the audit and the inspections for this kind of factory and sites who are [00:14:15] producing products directly for the European U.Chenchao: S. market are scrutinized. And but not in the direct way. It's just, as I said, a lot of confidence, fear of to be imprisoned, fear of to be Questions on the [00:14:30] airport that's why many inspectors are refusing to fly to China to do their audit job, which is very concerning because even there's nothing happened alone, this kind of angst, this kind of uncertainty is not very good [00:14:45]confidence for business.Chenchao: And we know if their sites and the manufacturer entities are not a certified, they are not allowed to sell products in the board. And. This doesn't only harm business, it just can harm patient's health, safety, [00:15:00] and patient care. So we really have to act fast and to come to a really good pragmatic agreement.Chenchao: So there's reinstalled the confidence. I think at the end of the day, we cannot regard business or economic ize only on paper, [00:15:15] on legal. But rather on people's perception, we have to regain the confidence we have to regain that China is a reliable partner and not just being said, not just put on paper, but lived by [00:15:30] example.Chenchao: I think this is also an effort we, both sides, need to make an effort. Art: Yeah, and I see that on the U. S. China side as well, there's a perception and, it's hard to say exactly [00:15:45] what the reality is, but there's a perception. That recently, especially that it's not safe for executives to travel to China.Art: And even the U S state department has put out a travel advisory last year about that did warning executives [00:16:00] to, from, for traveling from the U S to China that they may get questioned or may not be able to come back on the exact flight they had originally planned and so forth. So even if those concerns, or even if that's not exactly the way it is in reality.[00:16:15]Art: There's those perceptions, like you said, and that affects real business decisions and planning for investments and audits, like you said it does affect things. And I'll stick with regulations because you mentioned the anti espionage law and, a lot of that has also to do with [00:16:30] some of the.Art: The data regulations that come out, and those have also come out and been implemented very quickly and almost the regulators are trying to catch up because companies have concerns. How do I implement the PIPL in my business? And this doesn't [00:16:45] add up and this doesn't make sense. And the regulators, particularly the cyber security administration there, they've had to.Art: Been in catch up mode, I think, especially the last couple of years. So how have these regulations, of course, Europe is very in Germany, and I'm very familiar with [00:17:00] GDPR and how have these regulations for especially the PIPL in China, the data protection law, how has that affected cross border healthcare collaborations and data sharing recently?Chenchao: Yeah. Thank you, Arda. I think this is [00:17:15] very crucial questions. I think in that field is very also innovative, new, of course, the get challenged by the industries, big tech companies but the AI act, digital market act. So there's a lot of initiative [00:17:30] legislations where your European union employs to be very on the frontier of the regulation of the digital era.Chenchao: GDPR has been for a long time. I think it is very restrictive law. It's protects [00:17:45] the data very strongly, and it's also becomes even, people criticize to be very bureaucratic to be very, noisy. But somehow in the international level, it's also receives a positive [00:18:00] example set by the European Union.Chenchao: This is when it's come to China, also some positive thing to, to tell about the China because the privacy law. It has been improved, has been introduced, and also follow some of the [00:18:15]patterns by GDPR as a good leadership in that regard. But again, the law is only has its value when it's enforced, right?Chenchao: So this is a discrepancy, I think, not only a problem China faces, but in many countries [00:18:30] as well. But in that regard, China is definitely doing better. But, and also there's a concession, I think, also due to the recent diplomatic warm up that China allows data outflow again of company related data for big [00:18:45] companies.Chenchao: I think this is very important to rebuild the trust, rebuild the confidence. I think, similar to the topic of the capital outflow, very sensitive, but also very important topic. And because China need to [00:19:00] have confidence and the favorite investors and company. So I think this was the right step.Chenchao: And I do think this has to be even more in the long term to be rebalanced, renegotiated. When it comes to other legislations as you mentioned, [00:19:15] espionage law, I think in general speaking they are very, of course follow a certain pattern of, what happens in the U. S.,Chenchao: Following the 9 11 Patriot Act. So China tries also to have very strong [00:19:30]regulations and legislative, toolboxes to, to survey and also monitor citizens, companies, and to have very strong executive powers in case of unseen danger for the national security.Chenchao: But the [00:19:45] law is, it's very expensive and very widely weak interpreted. And this is also led to the suspicion and also the threat and by people who read the law just to be very hard to [00:20:00] appropriate when which case applies, which not, I think it does need more concretized formulation to make sure that, no more operations, especially in the very crucial areas in pharmaceutical [00:20:15] manufacturing are not hindered and prohibited.Chenchao: And because I think China as a nation of a modern industry is very keen to become a leadership in digital [00:20:30] health in, in, in clinical trials providers. And also to be, very strong out licensing production site. So China itself need to say a very open environment. And I think the government is more and [00:20:45] more keen to understand that it's not just do a favor for a foreign company, but more and more it's actually very imperative for China.Chenchao: For the Chinese firm to succeed on the global stage, Art: that's a good point. That's a [00:21:00] good way of putting it that, that, maybe in some ways it felt like the regulations are there to protect local Chinese companies, but at some point you don't want to keep protecting them if it means, if it prevents them from becoming globally competitive.Art: So we, and we [00:21:15] touched on the. The market opportunities a bit and some of the macro trends that are shaping the industry and the opportunity there in China. But I wanted to go back to that a bit still. There's an aging population in China and there's also a global increase in kind of [00:21:30] the health consciousness post COVID, especially in China.Art: I noticed when I was living there. So what macro trends do you believe are continuing to reshape the industry in China and pulling. Foreign companies to, to keep working there and keep looking for [00:21:45] opportunities. Chenchao: Yeah, I think China has been facing multiple fronts of challenges, right? I think the big factor you just mentioned is the COVID wave which the implication repercussions are still to be failed and to be seen [00:22:00] and to be recovered.Chenchao: And we have a lot of issues within this company and, we have very strong loss confidence in the stock market in Hong Kong. Almost two digits trailing off value was webbed out and [00:22:15]we have a problem with the company who don't want to go IPO at all. We have property market is collapsing which makes up to almost a one fifth of the GDP.Chenchao: So there's a lot of big issues within the [00:22:30] company within the country. And we have a declining population, we, the population already picked and not only that the number, but also, especially we're talking about an area in India, the population is still very young there under [00:22:45]30 where here is aging very rapidly.Chenchao: And and then also, I think this is something which people hardly want to talk about. Is, we know that the government is very powerful, where it's strong and very directive. But [00:23:00] once you come to people's reproduction the limitation is also to be observed, right? So you cannot dictate everything.Chenchao: And so it's very important to create a society and environment where people feel safe, feel protected, feel [00:23:15] supported to have children. And also to cope with the fact, okay, what do we do as government, as a society, if the birth rate is not increasing, so we have to make people more productive to make sure that we create the opportunity [00:23:30] for people, especially in the health care sector, when it comes to care nursing, I think.Chenchao: And we have a lot of things to catch up when it comes to the systematic education where already a lot of things have been, transferred and learned from the West, especially when [00:23:45] it comes to machinery and automobile, but now it's have to shift more to health care and service areas. And which is already taking place, and this is why China needs open dialogues, open collaboration [00:24:00] with us.Chenchao: It's not only just keep the markets open, but keep the people safe, keep the patients served. And this is something we have to have a longer run, longer view to make sure this is happening. I think this is a very, [00:24:15] pressing issue the Asian population. But I do think, we, we can create a system where it's also the, questions linger in the second level when it's come to the problem of who call, the residency.Chenchao: There's [00:24:30] come to the issue like universal income, and it's a very big disparity of wealth disparity of big. So this are all connected dots, when it's come to the question why people don't want to give birth, why we don't have confidence in [00:24:45] the country to thrive and So I think this is take a long run to, to rebuild everything.Chenchao: But I think it's very good start to really, to ensure very valuable and needed jobs like nursing, healthcare professionals, [00:25:00] and also to tackle the problem of youth unemployment. Art: Yeah, lots of macro challenges there. And it's you're right. The, also the government there, it takes some somewhat of, I guess you could call it like a [00:25:15] paternalistic kind of approach in some ways it doesn't, in some ways it's very hands off, maybe two hands off, but one way it does take the a very, It does get very involved, and especially compared to the U.Art: S. where, the U. S. where health care costs are pretty, pretty out of [00:25:30] control. China has this volume based pricing system to try to control health care costs as best as it can. I know I've used the public health system in China and some of the public hospitals, and I'm amazed at how inexpensive the costs [00:25:45] are.Art: Now, of course, if you're looking, if you're going into the hospitals there in Shanghai, you see they have this very expensive equipment. But they're using it at a mass production kind of scale. You use a CT scan there. It's like a factory. They're getting people in and out. [00:26:00] So I wonder for at least maybe going back to the volume based pricing that a lot of the government requires for firms, including foreign firms that are doing business there.Art: How have foreign firms, let's say from Germany or the EU how have they [00:26:15] struggled with that policy? In, in, In their market approach in China, or maybe they've just learned to adapt to it, right? Maybe it's more similar to some of the pricing policies that they've faced in Europe. The US, of course, is [00:26:30] those companies probably face less of that.Chenchao: Yeah, I think this is a very interesting and impactful for questions. And when it comes to access to healthcare providers and [00:26:45] access to the best solution, innovation and pharmaceuticals. So I think when it comes to procurement strategy, Chinese government, and this is also where you see, central government's power compared to capitalism driven forces in the U.Chenchao: [00:27:00] S. Where, 18 percent GDP are spent on healthcare, where a lot of money is spent, but the outcome is not where we, good compared to much of the cheaper system in the European Union. But when it comes to China, I think there's a lot of reforms happening, [00:27:15] for decades.Chenchao: We have different reforms of Chinese FDA to national it got products and administration. So a lot of things have been changed. And I also, over the 30 provinces in China have been also consolidated to [00:27:30] one central pricing negotiation scheme within central government, which also voice.Chenchao: It's a provincial government competing each other and to set a different level of pricing, which can not be benefiting the patient or [00:27:45] hospital system. So the power of central government negotiates on pricing is very huge. And in China, for many in therapeutic areas, we already see the lowest price.Chenchao: Globally, even lower than some [00:28:00] African countries. So China is very strong when it comes to pushing the price down over 90%. Did a deduction reduction is not a rare. So the questions as you ask, what does it mean for their foreign companies? I think [00:28:15] still many companies, of course, they fall. They say, okay, under certain price, we don't want to play anymore.Chenchao: But big names and the big companies still being not only, I think, just to be in the [00:28:30]market, to please the government, to really be not screwing in nice. It's also because a question of how long the view you took at it. So because I think big companies operating the more strategic long term in decades, not in [00:28:45] years.Chenchao: So they know that it's very important to stay within the system. And they also know the system can work against them in short term, but it can also improve in favor of them in short term. Because Chinese systems is always [00:29:00] dynamic and very flexible. And and also to be fair Chinese population is huge.Chenchao: And that's why even the price is low, even the, perfect margin percentage wise is low, but the absolute number is still [00:29:15] enormous. And I think the second point, Art, is also to mention, because we have observed a strong censorship in China, of course, but, of course, the people and patients can still access a lot of [00:29:30] information outside of China.Chenchao: And they learn and know a lot about innovation happening in China. In the pipelines and the new introduction of drugs, and they want to get it, and they want to say, Hey, why we don't have it. Why is only [00:29:45] access in the Europe and American market. It's a pressure come also from bottom, and this puts the government also in the position to even they don't want to let in maybe too many foreign drugs because they want to promote [00:30:00] the domestic brands, domestic company, also because they're expensive, they don't want to, pay from the, insurance scheme, though, but I think this is very good.Chenchao: Dynamics to help to balance the power to not [00:30:15] only one side to dictate what is sold on the market, but also to make sure and, compared to the extreme in the U. S. That only let the market a player in company to dictate the price and the scheme. So [00:30:30] I think this is what China needs, a balanced approach.Chenchao: I think Europe has a pretty good example to set when we look at Denmark, Germany where it, there's a market dictation, but also government [00:30:45] monitoring. And I think this is a way to go. Art: Yeah, that makes sense. And that's a very good point. You mentioned about it's not just necessarily a top down approach from the Chinese government that they have to be responsive to what [00:31:00]their consumers or the constituents want and they hear about drugs overseas and say, why is that not available here?Art: That's a great point. I think by this interview, you've made it very clear with the audience that this is a topic you can speak very clearly about [00:31:15] and very and a real depth. And I wonder if, 1st, I would encourage again, people to check out your company and website, this great testimonials and endorsements from the companies that you've worked with.Art: It's really impressive, very big name companies. So I can tell the work you're [00:31:30] doing as a. Has a big impact and is getting results. And I wonder if people want to reach out to you. After listening to this show, what's the best way for people to reach out to you? Is it LinkedIn or is it go to your website or all of the above?[00:31:45]Chenchao: Yeah. for for asking. Yeah. I think I'm very easy, accessible to be found on LinkedIn or very easy c.liu@silreal.com. Yeah, happy to hear your [00:32:00] feedback and your comments also on the conversation right now I'm having with art and also have help to any endeavors that might come across.Chenchao: very much. Art: Yeah, that's great. We'll put a link up to the site on the show notes as well. [00:32:15] And and I'm sure people will reach out to you. So once again, Chen Chao, thank you for coming on. It's been a pleasure talking with you.   https://www.asiabusinesspod.com/

On this episode, I'm joined by Kalyan Peri, Chief Information Officer of Commercial Business at Conduent. His life story is not just about the ascent to technological leadership but also about the values and experiences that shape a visionary over the course of a lifetime.Key Takeaways:(00:50) Village upbringing had a profound and lasting impact on Kalyan.(01:08) Grandparents share their wisdom on character development and future aspirations.(01:16) Experiences at elite institutions proved to be life-changing. (03:25) Transitioning from a tranquil village to the dynamic world of technology.(09:06) Kalyan journeyed from a small village to being a beacon of innovation.(15:53) Identify what drives you to make progress in life.(21:10) Balance the scales of personal well-being with professional success.(26:06) The right friends will help you reach your goals. (37:42) Technology can be a lever for societal benefit, with a spotlight on healthcare.(45:01) Looking ahead with a vision to leverage technology for the common good.(46:34) Emphasizing the importance of health, education and continuous personal growth.Resources Mentioned:Kalyan Peri - https://www.linkedin.com/in/kalyanperi/Conduent - https://www.linkedin.com/company/conduent/Indian Institutes of Technology (IITs) - https://www.iitsystem.ac.in/Infosys - https://www.infosys.com/Thanks for listening to the Indianness podcast. If you enjoyed this episode, hit the subscribe button and never miss another insightful conversation with leaders of Indian origin. And be sure to leave a review to help get the word out about the show. #Indian #IndiaBusiness #India #Indianness

Following the upgrade of the US Healthcare sector to most preferred, Eric Potoker explains the allocation shift and sub-sector views within the broader group. We also spend time discussing healthcare-related investment themes, along with the investment risks to be mindful of. Featured is Eric Potoker, Healthcare Sector Strategist Americas, UBS Chief Investment Office. Host: Daniel Cassidy

The Art of Global Dealmaking: Insights from Leanne  Carling on The Deal Scout PodcastWelcome to the podcast, fellow dealmakers and entrepreneurs! I'm Josh, the host of "The Deal Scout" podcast, where we dive into the intricate world of deals and acquisitions. Today, I'm thrilled to share with you the insights from a recent episode featuring the remarkable Leanne Carling. In just seven minutes, we uncovered a wealth of knowledge about global dealmaking that I'm eager to pass on to you.From Dundee to Dubai: Lianne Carling's Journey in Property and BusinessLeanne Carling's story is one of ambition and strategic growth. Starting in 2008, Leanne began her journey in property acquisition in Dundee, Scotland. Over a decade, she expanded her portfolio to include children centers, building services companies, healthcare, and dental practice roll-ups. Her approach to dealmaking is dynamic, always on the lookout for new opportunities while managing an impressive array of existing ventures.Going Global: The Shift from Local to International DealsThe transition from local to international dealmaking is a leap that many entrepreneurs aspire to make. For Leanne and her husband, this meant moving their base from Scotland to Dubai. The strategic relocation was driven by the desire to operate from a global hub, making it easier to travel and source deals from a fresh perspective.Learning the Ropes of International BusinessWhen venturing into new territories, understanding the local environment is crucial. Leanne emphasizes the importance of adapting to different cultures and overcoming language barriers. Partnering with knowledgeable locals, whether they are lawyers, accountants, or business advisors, has been a key strategy in navigating these challenges.The Hunt for Deals: Strategies and Criteria for SuccessLeanne's favorite aspect of dealmaking is the hunt—the process of sourcing and identifying potential deals. She advises having a strict set of criteria to quickly assess opportunities. This includes knowing the sector, desired turnover, number of employees, and location. As deals are analyzed, criteria may tighten or widen, but having a clear starting point is essential.Red Flags and Deal BreakersWhen it comes to red flags, Leanne is cautious about businesses lacking proper management structures. A well-managed business that can continue to thrive post-acquisition is a top priority. Motivations for selling, such as retirement due to health issues, can also be a red flag if there's no clear management succession plan.The Current Appetite: A Focus on HealthcareCurrently, Leanne's focus is on the healthcare sector, driven by the fact that people are living longer and spending more on health and aesthetics. The demand for home care services is particularly high, presenting numerous opportunities for savvy dealmakers.Connect with Leanne Carling and The Carling Grouphttps://www.linkedin.com/in/leanne-carling/https://www.thecarlinggroup.com/Conclusion: As we continue to explore the world of deals on The Deal Scout podcast, I hope these insights inspire you to broaden your horizons and pursue your own global ambitions.Next Steps Share your thoughts with a review - https://www.thedealscout.com/reviews/ Let's connect on LinkedIn - https://www.linkedin.com/in/joshuabrucewilson/ Subscribe and Watch on YouTube - https://www.youtube.com/channel/UCBQN_Y3nhDGClfMxCSBDjOg

Investors might be wise to look beyond a stock's yield and instead choose stocks with durable dividends and buy those stocks when they're undervalued. Today's Stocks & Topics: NKE - Nike Inc. Cl B, DVN - Devon Energy Corp., APA - APA Corp., VCSH - Vanguard Short-Term Corporate Bond ETF, Capital One and Discover Deal, Healthcare Sector, VHT - Vanguard Health Care ETF, JEPI - JPMorgan Equity Premium Income ETF, SCHD - Schwab US Dividend Equity ETF, ESS - Essex Property Trust Inc., Invest in US Farmland, TROW - T. Rowe Price Group Inc., Tax Exempt, Recession, Japan.Our Sponsors:* Check out Rosetta Stone and use my code TODAY for a great deal: https://www.rosettastone.com/Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Join us for an insightful conversation with Joanie Biley. With her extensive 30-year background in talent acquisition and as the Chief Experience Officer at EmployBridge, Joanie shares her analysis of the present and future job market. She'll divulge predictions for a softening in the 2024 job growth, the digital transformation in recruiting through AI, and the importance of technology for competitive edge in talent acquisition.Get ready for strategic insights on upskilling the workforce, and a discussion on the challenges and opportunities staffing firms face in current legislation. Joanie will share her expertise on building lasting relationships and sales in a shifting market, and we'll underline the value of strategic engagement and prioritizing what's within our control in uncertain times.Tune in for a comprehensive look at what will drive the labor market in 2024, and how to find balance and opportunity amidst it all, with Joanie Bily's expertise leading the way.

On today's episode, we are excited to welcome Dr. David Cunic, the CEO of UCS Advisors. David is a physical therapist turned Investor Relations and Networking Expert, particularly specializing in the Cannabis Industry and Healthcare Sector. With over 18 years in the medical field and an impressive entrepreneurial track record of starting over 10 companies, leading seven Cannabis businesses in the U.S., he has become an inspiration for entrepreneurs and business owners. His academic foundation in physical therapy and healthcare management, combined with his hands-on experience in business development and capital fundraising, has positioned him as a pivotal figure for Cannabis companies aiming to reach new heights of success. In today's episode, David and Andrew discuss:  How he went from physical therapy to working in investor relations His experience with entrepreneurship and how he started working in Cannabis How to build an effective pitch deck and what to avoid when presenting to investors  Current trends in investor markets and what has changed in recent years  How accountants can help their clients achieve greatness in business and how to build confidence while raising capital in Cannabis Dive right in with our much anticipated conversation with Dr. David Cunic. --- Send in a voice message: https://podcasters.spotify.com/pod/show/dopecfo/message

This week on the Million Dollar Mastermind podcast, host Larry Weidel is joined by Dr. Harry Leider, Chief Executive Officer at Organicell Regenerative Medicine, a South Florida-based clinical-stage biopharmaceutical company principally focused on the development of innovative biological therapeutics for the treatment of chronic diseases and the provision of related services.